Adam R Kinney, Lisa A Brenner, Rishi Deka, Xiang-Dong Yan, Jeri E Forster, Christi S Ulmer, Paul N Pfeiffer, Dara Ganoczy, Jennifer L Martin, Haylee Yepson, Nazanin H Bahraini
{"title":"Guideline-Concordant Cognitive Behavioral Therapy for Insomnia in the Veterans Health Administration Polytrauma/Traumatic Brain Injury System of Care.","authors":"Adam R Kinney, Lisa A Brenner, Rishi Deka, Xiang-Dong Yan, Jeri E Forster, Christi S Ulmer, Paul N Pfeiffer, Dara Ganoczy, Jennifer L Martin, Haylee Yepson, Nazanin H Bahraini","doi":"10.1080/15402002.2025.2563555","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment over medication. However, its use among Veterans in the Polytrauma/Traumatic Brain Injury System of Care (PSC) - a high-riskgroup for insomnia and medication complications - remains unclear. We describe CBT-I utilization in the PSC and identify predictors of receiving CBT-I.</p><p><strong>Method: </strong>We analyzed medical records of Veterans who initiated PSC services after 10/1/2019 and received either first-line CBT-I or sleep medications within one year. We modeled the likelihood of receiving first-line CBT-I vs. medications based on sociodemographic, clinical, spatial access (e.g. drive time), and facility-level factors (e.g. patient-reported access).</p><p><strong>Results: </strong>Veterans who received insomnia treatment after initiating PSC services (N = 18,293) were 85% male, 61% White, 21% Black or African American,14% Hispanic, and 8% age 65 or older. Only 11% received first-line CBT-I. Older Veterans; Native Hawaiian/Pacific Islander and Hispanic Veterans; those with bipolar disorder, depression, and alcohol use or other substance use disorders; and those with extended drive times were less likely to receive CBT-I. Findings were consistent in the sensitivity analysis.</p><p><strong>Conclusions: </strong>Veterans were approximately eight times more likely to receive medications than CBT-I. Implementation strategies that overcome barriers toguideline-concordant care in the PSC are needed.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"119-132"},"PeriodicalIF":2.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioral Sleep Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15402002.2025.2563555","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment over medication. However, its use among Veterans in the Polytrauma/Traumatic Brain Injury System of Care (PSC) - a high-riskgroup for insomnia and medication complications - remains unclear. We describe CBT-I utilization in the PSC and identify predictors of receiving CBT-I.
Method: We analyzed medical records of Veterans who initiated PSC services after 10/1/2019 and received either first-line CBT-I or sleep medications within one year. We modeled the likelihood of receiving first-line CBT-I vs. medications based on sociodemographic, clinical, spatial access (e.g. drive time), and facility-level factors (e.g. patient-reported access).
Results: Veterans who received insomnia treatment after initiating PSC services (N = 18,293) were 85% male, 61% White, 21% Black or African American,14% Hispanic, and 8% age 65 or older. Only 11% received first-line CBT-I. Older Veterans; Native Hawaiian/Pacific Islander and Hispanic Veterans; those with bipolar disorder, depression, and alcohol use or other substance use disorders; and those with extended drive times were less likely to receive CBT-I. Findings were consistent in the sensitivity analysis.
Conclusions: Veterans were approximately eight times more likely to receive medications than CBT-I. Implementation strategies that overcome barriers toguideline-concordant care in the PSC are needed.
期刊介绍:
Behavioral Sleep Medicine addresses behavioral dimensions of normal and abnormal sleep mechanisms and the prevention, assessment, and treatment of sleep disorders and associated behavioral and emotional problems. Standards for interventions acceptable to this journal are guided by established principles of behavior change. Intending to serve as the intellectual home for the application of behavioral/cognitive science to the study of normal and disordered sleep, the journal paints a broad stroke across the behavioral sleep medicine landscape. Its content includes scholarly investigation of such areas as normal sleep experience, insomnia, the relation of daytime functioning to sleep, parasomnias, circadian rhythm disorders, treatment adherence, pediatrics, and geriatrics. Multidisciplinary approaches are particularly welcome. The journal’ domain encompasses human basic, applied, and clinical outcome research. Behavioral Sleep Medicine also embraces methodological diversity, spanning innovative case studies, quasi-experimentation, randomized trials, epidemiology, and critical reviews.